Shahzad Malik, Director at Iterum Therapeutics plc (ITRM), bought 455,322 shares at $13.00 ($3.1M) on 2018-05-30, disclosed to the SEC on 2018-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 218,338 | $0 | 0.0% |
| 2 | $13.00 | 8,144 | $106K | 3.4% |
| 3 | $13.00 | 228,840 | $3.0M | 96.6% |
| Total | $6.77 avg | 455,322 | $3.1M | 100% |
| Filing → |
| AGEN | SELL | 2015-04-30 | $7.9M | — | Filing → |
| VSAR | BUY | 2015-01-26 | $949K | — | Filing → |
| VSAR | BUY | 2014-03-27 | $1.3M | — | Filing → |